A new U.S.-based pharmaceutical manufacturer, Tailstorm Health, Inc., DBA Medivant Healthcare, will begin to roll out sterile single dose liquid injectable medications on the FDA’s Drug Shortage List. Medivant’s initial products will include sterile liquid injectables that are in dire need in the ICU for COVID-19 patients.   Throughout the country, hospitals have experienced difficulties receiving orders for more than a dozen sedatives, anesthetics, painkillers, and muscle relaxants,...